Lipoglycopeptides [EXT] - N0000191280

Pharmacologic Code	N0000191280
Pharmacologic Name	Lipoglycopeptides
Pharmacologic Uses	lipoglycopeptide antibacterial
Pharmacologic Concept	Terminology Extensions for Classification - [EXT]
Pharmacologic Concept Description	A local MED-RT extension primarily with chemical classification concepts requested by FDA SPL for eventual addition to NLM MeSH, beneath the "Terminology Extensions for Classification [EXT]" concept, mapped to MeSH hierarchy concepts if possible.

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptides [EXT].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	57970-100	Dalvance	Non-Proprietary Name: Dalbavancin	Injection, Powder, For Solution	Intravenous	Allergan, Inc.	ACTIVE
	66220-315	Vibativ	Non-Proprietary Name: Telavancin Hydrochloride	Injection, Powder, Lyophilized, For Solution	Intravenous	Cumberland Pharmaceuticals Inc.	ACTIVE